Registrati | Log in | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

di jyuh Bakris [43 articles]

Articoli recentemente aggiunti di jyuh nella biblioteca scritti da Bakris. Puoi anche vedere see Bakris di tutti gli articoli.
  • CKD awareness in the United States: the Kidney Early Evaluation Program (KEEP).
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 52, No. 2. (August 2008), pp. 382-383.
    by G Saab, AT Whaley-Connell, PA McCullough, GL Bakris
    posted to keep ckd by jyuh on 2008-11-08 09:05:25 as **
  • The rationale and design of the AASK cohort study.
    Journal of the American Society of Nephrology : JASN, Vol. 14, No. 7 Suppl 2. (July 2003)
    by LJ Appel, J Middleton, ER Miller, M Lipkowitz, K Norris, LY Agodoa, G Bakris, JG Douglas, J Charleston, J Gassman, T Greene, K Jamerson, JW Kusek, JA Lewis, RA Phillips, SG Rostand, JT Wright
    posted to rct aask by jyuh on 2008-11-07 16:08:59 as **
  • Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes
    Journal of Human Hypertension, Vol. aop, No. current.
    by PA Sarafidis, AN Lasaridis, PM Nilsson, MI Pikilidou, PC Stafilas, A Kanaki, K Kazakos, J Yovos, GL Bakris
    posted to irs homa dm bp by jyuh on 2008-11-05 08:27:24 as **
  • Should a lower blood pressure goal and albuminuria reduction be mandated to slow hypertensive nephropathy?
    Current hypertension reports, Vol. 10, No. 5. (October 2008), pp. 387-388.
    by GL Bakris
    posted to uae ckd bp 1 by jyuh on 2008-11-05 08:23:06 as **
  • An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease.
    American journal of nephrology, Vol. 26, No. 3. (2006), pp. 268-275.
    by C Jones-Burton, SI Mishra, JC Fink, J Brown, W Gossa, GL Bakris, MR Weir
    posted to salt ckd by jyuh on 2008-11-05 07:07:22 as **
  • Combination therapy with Renin-Angiotensin-aldosterone receptor blockers for hypertension: how far have we come?
    Journal of clinical hypertension (Greenwich, Conn.), Vol. 10, No. 2. (February 2008), pp. 146-152.
    by MR Weir, GL Bakris
    posted to bp aceiarb by jyuh on 2008-10-31 03:39:42 as **
  • The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
    Archives of internal medicine, Vol. 165, No. 8. (25 April 2005), pp. 947-953.
    by J Lea, T Greene, L Hebert, M Lipkowitz, S Massry, J Middleton, SG Rostand, E Miller, W Smith, GL Bakris
    posted to rct proteinuria hd ckd bp 1 by jyuh on 2008-10-29 07:19:25 as **
  • Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.
    Archives of internal medicine, Vol. 168, No. 8. (28 April 2008), pp. 832-839.
    by LJ Appel, JT Wright, T Greene, JW Kusek, JB Lewis, X Wang, MS Lipkowitz, KC Norris, GL Bakris, M Rahman, G Contreras, SG Rostand, JD Kopple, FB Gabbai, GI Schulman, JJ Gassman, J Charleston, LY Agodoa,
    posted to rct race outcome ckd bp arb acei by jyuh on 2008-10-21 10:35:50 as **
  • Comparison of commonly used assays for the detection of microalbuminuria.
    Journal of clinical hypertension (Greenwich, Conn.), Vol. 6, No. 11 Suppl 3. (November 2004), pp. 8-12.
    by DE Busby, GL Bakris
    posted to uae method by jyuh on 2008-10-03 03:50:46 as **
  • Influence of microalbuminuria in achieving blood pressure goals.
    Current opinion in nephrology and hypertension, Vol. 17, No. 5. (September 2008), pp. 457-463.
    by I Duka, G Bakris
    posted to uae bp aceiarb by jyuh on 2008-10-01 17:13:42 as **
  • Albuminuria reduction and nephropathy progression.
    Current hypertension reports, Vol. 10, No. 5. (October 2008), pp. 388-389.
    by GL Bakris
    posted to uae ckd by jyuh on 2008-10-01 10:22:48 as **
  • The pathogenesis of diabetic nephropathy.
    Nature clinical practice. Endocrinology & metabolism, Vol. 4, No. 8. (August 2008), pp. 444-452.
    by S Dronavalli, I Duka, GL Bakris
    posted to uae dn by jyuh on 2008-10-01 05:27:48 as **
  • Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 42, No. 4. (October 2003), pp. 617-622.
    by G Eknoyan, T Hostetter, GL Bakris, L Hebert, AS Levey, HH Parving, MW Steffes, R Toto
    posted to proteinuria guideline ckd 1 by jyuh on 2008-09-30 13:41:12 as **
  • Slowing nephropathy progression: focus on proteinuria reduction.
    Clinical journal of the American Society of Nephrology : CJASN, Vol. 3 Suppl 1 (January 2008)
    by GL Bakris
    posted to treatment proteinuria ckd 1 by jyuh on 2008-09-13 08:32:05 as **
  • Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.
    Journal of hypertension, Vol. 25, No. 10. (October 2007), pp. 2082-2092.
    by V Bhatnagar, DT O'Connor, NJ Schork, RM Salem, CM Nievergelt, BK Rana, DW Smith, GL Bakris, JP Middleton, KC Norris, JT Wright, D Cheek, L Hiremath, G Contreras, LJ Appel, MS Lipkowitz
    posted to ace acei bp snp by jyuh on 2008-08-16 07:54:33 as **
  • Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
    Postgraduate medicine, Vol. 120, No. 1. (April 2008), pp. 33-42.
    by GL Bakris, MR Weir
    posted to aceiarb acei arb ckd by jyuh on 2008-07-20 15:17:06 as **
  • Beta blockers in the management of chronic kidney disease.
    Kidney international, Vol. 70, No. 11. (December 2006), pp. 1905-1913.
    by GL Bakris, P Hart, E Ritz
    posted to beta-blocker ckd by jyuh on 2008-06-28 06:17:04 as **
  • Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.
    Kidney international (21 May 2008)
    by George Bakris, Ellen Burgess, Matthew Weir, Giora Davidai, Stephen Koval
    posted to arb dn rct by jyuh on 2008-06-08 14:13:40 as **
  • Hypertension awareness, treatment, and control in chronic kidney disease.
    The American journal of medicine, Vol. 121, No. 4. (April 2008), pp. 332-340.
    by PA Sarafidis, S Li, SC Chen, AJ Collins, WW Brown, MJ Klag, GL Bakris
    posted to bp ckd by jyuh on 2008-05-05 04:08:30 as **
  • Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 51, No. 4 Suppl 2. (April 2008)
    by MV Rao, Y Qiu, C Wang, G Bakris
    posted to bp ckd keep nhanes by jyuh on 2008-04-24 03:02:23 as **
  • Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 51, No. 4 Suppl 2. (April 2008)
    by SI McFarlane, SC Chen, AT Whaley-Connell, JR Sowers, JA Vassalotti, MO Salifu, S Li, C Wang, G Bakris, PA McCullough, AJ Collins, KC Norris,
    posted to anemia ckd keep nhanes screening by jyuh on 2008-04-24 03:01:23 as **
  • Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
    Kidney Int (19 March 2008)
    by G L L Bakris, R D D Toto, P A A McCullough, R Rocha, D Purkayastha, P Davis
    posted to acei ccb diuretics dn proteinuria by jyuh on 2008-03-22 03:15:36 as **
  • Trials that matter: the effect of a fixed-dose combination of an Angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes.
    Ann Intern Med, Vol. 148, No. 5. (4 March 2008), pp. 400-401.
    by GL Bakris, M Berkwits
    posted to no-tag by jyuh on 2008-03-05 08:45:34 as **
  • Low birth weight is associated with chronic kidney disease only in men
    Kidney Int, Vol. 73, No. 5. (19 December 2007), pp. 637-642.
    by S Li, SC Chen, M Shlipak, G Bakris, PA Mccullough, J Sowers, L Stevens, C Jurkovitz, S Mcfarlane, K Norris, J Vassalotti, MJ Klag, WW Brown, A Narva, D Calhoun, B Johnson, C Obialo, A Whaley-Connell, B Becker, AJ Collins
    posted to lbw gender ckd by jyuh on 2008-02-19 09:18:26 as **
  • A comparative evaluation of various methods for microalbuminuria screening.
    Am J Nephrol, Vol. 28, No. 2. (2008), pp. 324-329.
    by PA Sarafidis, J Riehle, Z Bogojevic, E Basta, A Chugh, GL Bakris
    posted to uae method 1 by jyuh on 2008-02-14 09:38:36 as **
  • Implications of albuminuria on kidney disease progression.
    J Clin Hypertens (Greenwich), Vol. 6, No. 11 Suppl 3. (November 2004), pp. 18-22.
    by GL Bakris
    posted to no-tag by jyuh on 2008-02-14 08:53:23 as **
  • Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial.
    Kidney Int, Vol. 72, No. 7. (October 2007), pp. 879-885.
    by GL Bakris, L Ruilope, F Locatelli, A Ptaszynska, B Pieske, J de Champlain, MA Weber, I Raz
    posted to uae rct cv bp arb acei 1 by jyuh on 2008-02-14 08:46:49 as **
  • Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).
    Am J Kidney Dis, Vol. 51, No. 2. (February 2008), pp. 192-198.
    by OK Duru, S Li, C Jurkovitz, G Bakris, W Brown, SC Chen, A Collins, M Klag, PA McCullough, J McGill, A Narva, P Pergola, A Singh, K Norris
    posted to race keep gender ckd bp by jyuh on 2008-02-13 06:38:41 as **
  • Should beta-blockers be used to control hypertension in people with chronic kidney disease?
    Semin Nephrol, Vol. 27, No. 5. (September 2007), pp. 555-564.
    by PD Hart, GL Bakris
    posted to beta-blocker bp ckd by jyuh on 2007-11-11 02:19:50 as **
  • Microalbuminuria: what is it? Why is it important? What should be done about it? An update.
    J Clin Hypertens (Greenwich), Vol. 9, No. 3. (March 2007), pp. 196-200.
    by A Chugh, GL Bakris
    posted to uae by jyuh on 2007-10-04 05:10:06 as ****
  • The effect of ruboxistaurin on nephropathy in type 2 diabetes.
    Diabetes Care, Vol. 28, No. 11. (November 2005), pp. 2686-2690.
    by KR Tuttle, GL Bakris, RD Toto, JB McGill, K Hu, PW Anderson
    posted to no-tag by jyuh on 2007-09-14 03:34:18 as **
  • Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
    Circulation, Vol. 115, No. 1. (2 January 2007), pp. 114-126.
    by JB Buse, HN Ginsberg, GL Bakris, NG Clark, F Costa, R Eckel, V Fonseca, HC Gerstein, S Grundy, RW Nesto, MP Pignone, J Plutzky, D Porte, R Redberg, KF Stitzel, NJ Stone, ,
    posted to no-tag by jyuh on 2007-08-21 04:13:21 as **
  • Renoprotection: ACE-I and ARBs: Rebuttals
    (2006)
    by George Bakris
    posted to no-tag by jyuh on 2007-08-01 08:34:43 as **
  • Renoprotection Debate: ACE-I and ARBs May Not Be Essential
    (2006)
    by George Bakris
    posted to no-tag by jyuh on 2007-08-01 08:25:09 as **
  • Lessons Learned from Recent Hypertension Trials about Kidney Disease
    Clin J Am Soc Nephrol, Vol. 1, No. 2. (1 March 2006), pp. 229-235.
    by Nitin Khosla, George Bakris
    posted to rct ckd bp 1 by jyuh on 2007-08-01 07:06:38 as **
  • Microalbuminuria: What Is It? Why Is It Important? What Should Be Done About It? An Update
    The Journal of Clinical Hypertension, Vol. 9, No. 3. (2007), pp. 196-200.
    by Atul Chugh, George L Bakris
    posted to no-tag by jyuh on 2007-08-01 02:58:40 as **
  • Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program
    Kidney International, Vol. 67, No. 4. (April 2005), pp. 1483-1488.
    by M El-Achkar, E Ohmit, A Mccullough, D Crook, W Brown, Grimm Richard, L Bakris, F Keane, M Flack
    posted to no-tag by jyuh on 2007-07-29 04:08:42 as **
  • Microalbuminuria.
    Clin Lab Med, Vol. 26, No. 3. (September 2006)
    by N Khosla, PA Sarafidis, GL Bakris
    posted to no-tag by jyuh on 2007-07-29 02:10:42 as **
  • Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease.
    Nephrol Dial Transplant, Vol. 21, No. 9. (September 2006), pp. 2366-2374.
    by PA Sarafidis, GL Bakris
    posted to uae cv ckd by jyuh on 2007-07-29 02:01:00 as **
  • Antihypertensive therapy in the presence of proteinuria.
    Am J Kidney Dis, Vol. 49, No. 1. (January 2007), pp. 12-26.
    by PA Sarafidis, N Khosla, GL Bakris
    posted to proteinuria bp by jyuh on 2007-07-29 01:57:20 as **
  • Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues.
    Semin Nephrol, Vol. 24, No. 2. (March 2004), pp. 168-175.
    by AJ Mangrum, GL Bakris
    posted to no-tag by jyuh on 2007-07-24 17:21:53 as **
  • ACE inhibitors and ARBs: are they better than other agents to slow nephropathy progression?
    J Clin Hypertens (Greenwich), Vol. 9, No. 6. (June 2007), pp. 413-415.
    by GL Bakris
    posted to no-tag by jyuh on 2007-07-19 06:04:17 as **
  • Independent Components of Chronic Kidney Disease as a Cardiovascular Risk State: Results From the Kidney Early Evaluation Program (KEEP).
    Arch Intern Med, Vol. 167, No. 11. (11 June 2007), pp. 1122-1129.
    by PA McCullough, CT Jurkovitz, PE Pergola, JB McGill, WW Brown, AJ Collins, SC Chen, S Li, A Singh, KC Norris, MJ Klag, GL Bakris,
    posted to ckd cv keep by jyuh on 2007-06-21 16:54:07 as **
    • Puoi citare questa pagina come: http://www.citeulike.org/user/jyuh/author/Bakris

    RIS BibTeX